ES2038676T3 - Nuevos mejoradores de absorcion percutanea, composiciones que los contienen y metodo de uso. - Google Patents

Nuevos mejoradores de absorcion percutanea, composiciones que los contienen y metodo de uso.

Info

Publication number
ES2038676T3
ES2038676T3 ES198787310141T ES87310141T ES2038676T3 ES 2038676 T3 ES2038676 T3 ES 2038676T3 ES 198787310141 T ES198787310141 T ES 198787310141T ES 87310141 T ES87310141 T ES 87310141T ES 2038676 T3 ES2038676 T3 ES 2038676T3
Authority
ES
Spain
Prior art keywords
dioxacycloalkanes
compositions
new
improvers
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787310141T
Other languages
English (en)
Inventor
Carlos M. Samour
Stefanos Daskalakis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Macrochem Corp
Original Assignee
Macrochem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macrochem Corp filed Critical Macrochem Corp
Application granted granted Critical
Publication of ES2038676T3 publication Critical patent/ES2038676T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/12—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/16—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE PROPORCIONAN NUEVOS 1,3-DIOXACICLOALCANOS JUNTO CON NUEVAS COMPOSICIONES DE 1,3-DIOXACICLOALCANO, QUE SON UTILES PARA MEJORAR LA ABSORCION DE AGENTES TERAPEUTICOS A TRAVES DE LA PIEL DE HUMANOS Y ANIMALES. TAMBIEN SE DESCRIBE EL METODO PARA MEJORAR LA PENETRACION EN LA PIEL DE AGENTES TERAPEUTICOS UTILIZANDO 1,3-DIOXAXICLOALCANOS. LOS COMPUESTOS PREFERIDOS SON 1,3-DIOXACICLOALCANOS Y 1,3-DIOXANOS (1,3-DIOXACICLOHEXANOS). LOS COMPUESTOS PREFERIDOS TIENEN LA FORMULA:(I) EN LA QUE R, RO, R1, R2, R3, R4, R5 Y R6 SE ELIGEN CADA UNO INDEPENDIENTEMENTE DE HIDROGENO Y GRUPOS ALIFATICOS C1-C18, PREFERIBLEMENTE ALQUIL, ALQUENIL, HALO, HIDROXI, CARBOXI, CARBOXAMIDA Y SUS FORMAS DE CARBOALCOXI SUSTITUIDAS, CON POR LO MENOS UNO DE DICHOS R'', UN GRUPO ALQUILO O ALQUENILO C4-C8; Y N ES 0 O 1; SIENDO EL NUMERO TOTAL DE ATOMOS DE CARBONO EN TODOS LOS GRUPOS R NO MAS QUE 40, Y PREFERIBLEMENTE MENOS QUE 20, Y NO MAS QUE UNO DE ELLOS CONTIENE 18 O MAS ATOMOS DE CARBONO.
ES198787310141T 1986-11-17 1987-11-17 Nuevos mejoradores de absorcion percutanea, composiciones que los contienen y metodo de uso. Expired - Lifetime ES2038676T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/931,653 US4861764A (en) 1986-11-17 1986-11-17 Percutaneous absorption enhancers, compositions containing same and method of use

Publications (1)

Publication Number Publication Date
ES2038676T3 true ES2038676T3 (es) 1993-08-01

Family

ID=25461144

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787310141T Expired - Lifetime ES2038676T3 (es) 1986-11-17 1987-11-17 Nuevos mejoradores de absorcion percutanea, composiciones que los contienen y metodo de uso.

Country Status (7)

Country Link
US (1) US4861764A (es)
EP (1) EP0268460B1 (es)
AT (1) ATE69168T1 (es)
CA (1) CA1313619C (es)
DE (1) DE3774398D1 (es)
ES (1) ES2038676T3 (es)
GR (1) GR3003238T3 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU664178B2 (en) * 1991-03-19 1995-11-09 Vithal J. Rajadhyaksha Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
ATE169826T1 (de) * 1992-01-21 1998-09-15 Macrochem Corp Iontophoretische verbesserte verabreichung von medikamenten
EP0656356A1 (en) * 1992-08-21 1995-06-07 Japan Tobacco Inc. Dioxacycloalkane compound with renin-inhibiting activity
US5334615A (en) * 1992-12-17 1994-08-02 Walles Wilhelm E Oil with bactericidal and virucidal properties
US5637616A (en) * 1993-06-18 1997-06-10 Arcturus Pharmaceutical Corporation Method for treating diseases mediated by proteases
US5620980A (en) * 1995-02-22 1997-04-15 Macrochem Corporation Method for treating hair loss
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
WO1998011088A1 (en) * 1996-09-10 1998-03-19 Daiso Co., Ltd. Process for preparing 1,3-dioxolane-4-methanol compounds
DE69726441D1 (de) * 1996-09-10 2004-01-08 Daiso Co Ltd Verfahren zur herstellung von 1,3-dioxolan-4-methanol-verbindungen
DE19711758C2 (de) * 1997-03-21 2003-06-18 Degussa Verfahren zur Herstellung von 1,3-Dioxanverbindungen
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
US6153769A (en) * 1997-11-27 2000-11-28 Roche Vitamins Inc. Manufacture of polyene aldehydes
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
US5942545A (en) * 1998-06-15 1999-08-24 Macrochem Corporation Composition and method for treating penile erectile dysfunction
WO2000010540A1 (en) * 1998-08-20 2000-03-02 3M Innovative Properties Company Spray on bandage and drug delivery system
US7537773B1 (en) * 1998-08-25 2009-05-26 Botulinum Toxin Research Associates, Inc. Chemodenervating pharmaceutical as anti-inflammatory agent
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6596266B2 (en) 2000-02-18 2003-07-22 Natural Science, Inc. Compositions containing minoxidil and saw palmetto for treating baldness
US20050008602A1 (en) * 2000-06-05 2005-01-13 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
US7241731B2 (en) 2000-06-05 2007-07-10 Sumitomo Electric Industries, Ltd. Oligopeptides for promoting hair growth
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
JP2005513001A (ja) * 2001-11-09 2005-05-12 キュー エル ティー インク． 脱毛治療のための光力学療法
BR0308584A (pt) * 2002-03-15 2005-02-22 Unimed Pharmaceuticals Inc Composição farmacêutica androgênica e método para tratamento de depressão
CA2519707A1 (en) * 2003-03-21 2004-10-07 Nexmed (Holdings), Inc. Prostaglandin compositions for the treatment of erectile dysfunction
DK2106805T3 (da) 2003-03-21 2011-08-15 Nexmed Holdings Inc Antifungal neglelak og anvendelsesmetode
DE10314976A1 (de) * 2003-04-02 2004-10-14 Bayer Healthcare Ag Verbesserte Penetration von Wirkstoffen in Zellen und Organe
KR20050041815A (ko) * 2003-10-31 2005-05-04 싸이토팜(주) 자외선에 의한 피부손상을 경감시키는 항산화 조성물
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
FR2869232B1 (fr) * 2004-04-21 2007-09-21 Gattefosse Sas Soc Par Actions Nouveaux excipients pharmaceutiques ou cosmetiques a base d'acetals cyliques
KR20070121746A (ko) * 2005-03-14 2007-12-27 매크로켐 코포레이션 사람 피부를 통한 마크롤라이드 침투의 개선
JP2009504566A (ja) * 2005-05-11 2009-02-05 マクロケム コーポレイション 局所用組成物の低投薬量投与
GT200600396A (es) * 2005-09-07 2007-04-23 Dispositivos para la aplicacion de medicamentos transdermicos conteniendo o-desmetil venlafaxina (odv) o sus sales
GT200600397A (es) * 2005-09-07 2007-08-28 Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
JP5505760B2 (ja) 2005-09-27 2014-05-28 ティッシュテク・インコーポレーテッド 羊膜調製物及び精製組成物及びその使用方法
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
RS52671B (sr) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja
US20080319370A1 (en) 2005-11-04 2008-12-25 Acrux Dds Pty Ltd. Method and System for Transdermal Drug Delivery
EP2244690B1 (en) 2007-10-10 2017-08-02 Therametics, Llc Topical compositions for treating inflammatory disorders, diseases and conditions
JP5832451B2 (ja) 2010-06-11 2015-12-16 株式会社ポーラファルマ 抗真菌医薬組成物
US9682044B2 (en) 2011-06-10 2017-06-20 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
US9931423B2 (en) 2011-08-26 2018-04-03 Tissuetech, Inc. Methods of sterilizing fetal support tissues
WO2014066916A2 (en) 2012-10-28 2014-05-01 Revance Therapeutics, Inc. Compositions and methods for safe treatment of rhinitis
HK1243636A1 (zh) 2014-11-18 2018-07-20 Rutgers, The State University Of New Jersey 用於治疗代谢疾病和癌症的新的线粒体解偶联剂
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
EP3458454B1 (en) 2016-05-18 2021-11-24 Rutgers, The State University of New Jersey 2-hydroxy-n-(benzo[d]thiazol-2-yl)benzamide derivatives as mitochondrial uncouplers for the treatment of metabolic diseases and cancer
EP4740733A1 (en) 2024-11-12 2026-05-13 Uniwersystet Slaski w Katowicach Compositions of adjuvants and cosolvents for improving penetration of herbicides and/or fertilisers through surfaces of aboveground parts of plant organs.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1082370B (de) * 1958-01-18 1960-05-25 C F Asche & Co Ag Verfahren zur Herstellung von verformbaren Massen fuer kosmetische und pharmazeutische Zwecke
GB1385914A (en) * 1971-10-19 1975-03-05 Wigglesworth Ltd Compositions having bactericidal activity
US4012520A (en) * 1973-08-08 1977-03-15 The Upjohn Company Composition and method of producing infertility in male rodents
GB1448458A (en) * 1973-11-21 1976-09-08 Allen & Hanburys Ltd 1,3-dioxan derivatives and pharmaceutical compositions thereof
IT1037122B (it) * 1975-04-01 1979-11-10 Maggioni E C S P A Derivati alogenati dell 1 3 dios solano ad attivita mucolitica
ATE3292T1 (de) * 1978-11-30 1983-05-15 Imperial Chemical Industries Plc Zusammensetzungen, die 1,3 dioxolane als aufweichmittel enthalten.
CA1225594A (en) * 1983-05-20 1987-08-18 Jourge Heller Method for percutaneously administering physiologically active agents
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one

Also Published As

Publication number Publication date
ATE69168T1 (de) 1991-11-15
EP0268460B1 (en) 1991-11-06
EP0268460A1 (en) 1988-05-25
US4861764A (en) 1989-08-29
GR3003238T3 (en) 1993-02-17
DE3774398D1 (de) 1991-12-12
CA1313619C (en) 1993-02-16

Similar Documents

Publication Publication Date Title
GR3003238T3 (en) New percutaneous absorption enhancers, compositions containing same and method of use
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
DK387889A (da) Makrolider, og farmaceutiske praeparater med indhold af saadanne forbindelser
ES8103744A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ES2157593T3 (es) Derivados de la adenosina heterociclicos sustituidos en n6.
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
FI831230A0 (fi) N-glykosylerade karboxylsyraamidderivat, foerfarande foer deras framstaellning samt deras anvaendnifoer att paoverka kroppens eget foersvar
ES470458A1 (es) Procedimiento para la obtencion de sales de 1-(2-feniletil) triazolio de efecto fungicida
DE69011402D1 (de) Amidderivate und sie enthaltende Hautpräparationen.
GR71207B (es)
DK375079A (da) 3,4,5-trihydroxypiperidinderivater
SE8604950L (sv) Demensforbettrande och terapeutiska medel
IL82137A0 (en) Agents containing thiodiazolyl-ureas for defoliating plants
GR890300045T1 (en) Process for the preparation of 2,5-diamino-nitro-6-pyridine derivatives, their use in hair dyeing agents and these 2,5-diamino-6-nitro-pyridine derivatives
ATE69220T1 (de) Sechsgliedrige heterocyclische derivate von n'substituiertenn,n'-diacylhydrazinen.
FI96856C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoketonijohdannaisten valmistamiseksi
SU940629A3 (ru) Способ регулировани роста растений
ES2067452T3 (es) Rodomicinas semisinteticas, procedimiento para su preparacion y su empleo como citostaticos.
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
BR8600077A (pt) Compostos de n-(fosfonometilglicil)-sulfonilaminas,processo de preparacao,composicoes herbicidas e processo para a destruicao de ervas daninhas
ES540260A0 (es) Procedimiento para preparar derivados de 2-alcoxiaminosulfo-nilbencenosulfonilurea
SE8004622L (sv) Acylaminobensoesyraderivat
BG96041A (bg) Антивирусни тетрахидроимидазо /1,4/ бензодиазепини
ES2043778T3 (es) Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 268460

Country of ref document: ES